New paper: Quantitative drug susceptibility testing for M. tuberculosis using unassembled sequencing data and machine learning Philip Fowler, 14th August 202414th August 2024 This is the last paper from the initial set of CRyPTIC publications following the project’s data freeze in April 2020. The consortium takes a difference approach to that of (i) mapping the reads, (ii) look up the genetic mutations in a catalogue and (iii) return the predictions and instead trained a tree-based extreme gradient-boosted machine learning model. Since the minimum inhibitory concentration (MIC) was the label, the appropriate metrics are exact and essential agreement which mean “get the same MIC” and “get within one doubling dilution of the MIC”. The essential agreement is good for some drugs like ethambutol which have moderate sensitivities using the traditional binary approach which is expected due to their MIC distribution being almost unimodal. Also the good performance of the fluoroquinolones suggests that the model is able, in part at least, to learn the presence of minor alleles / subpopulations which we have shown elsewhere to be important for this class of drugs. But seriously: one figure and three tables? All those numbers in tables aren’t exactly easy to read and what I do I put for the thumbnail? (PWF can say this as technically he is an author and therefore it is partly his responsibility and therefore fault). Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Related antimicrobial resistance clinical microbiology publication tuberculosis
tuberculosis Numpy v Biopython 25th July 20194th August 2019 Having only recently having to write bioinformatics Python code that e.g. interrogate GenBank files to… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
SARS-CoV-2 pipeline live on EIT Pathogena 28th January 202528th January 2025 Back in the SARS-CoV-2 pandemic we worked closely with ORACLE Corp to build and deploy… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance New preprint: Deciphering bedaquiline and clofazimine resistance in tuberculosis 22nd March 202122nd March 2021 In this preprint we examine 14,151 clinical isolates drawn from the CRyPTIC dataset. Each isolate… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More